PHARMACOKINETICS OF CARISOPRODOL AT TWO DOSAGE LEVELS AND INFLUENCE OF CYP2C19 POLYMORPHISM ON ITS PHARMACOKINETICS IN HEALTHY CHINESE VOLUNTEERS

	PHARMACOKINETICS OF CARISOPRODOL AT TWO DOSAGE LEVELS AND INFLUENCE OF CYP2C19 POLYMORPHISM ON ITS PHARMACOKINETICS IN HEALTHY CHINESE VOLUNTEERS
	Zhang, Yifan1 ; Zhong, Dafang1 ; Chen, Xiaoyan1 ; Si, Dayong 2; Zhou, Hui 2
	2008
卷号	40
页码	153-153
会议录	DRUG METABOLISM REVIEWS
会议录出版者	TAYLOR & FRANCIS INC
文献子类	Meeting Abstract
语种	英语
WOS研究方向	Pharmacology & Pharmacy
WOS记录号	WOS:000265257500227
内容类型	会议论文
源URL	[http://119.78.100.183/handle/2S10ELR8/265950]
专题	上海药物代谢研究中心
作者单位	1.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Metab & Pharmacokinet Res, Shanghai 200031, Peoples R China; 2.Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China
推荐引用方式 GB/T 7714	Zhang, Yifan,Zhong, Dafang,Chen, Xiaoyan,et al. PHARMACOKINETICS OF CARISOPRODOL AT TWO DOSAGE LEVELS AND INFLUENCE OF CYP2C19 POLYMORPHISM ON ITS PHARMACOKINETICS IN HEALTHY CHINESE VOLUNTEERS[C]. 见:.